J. Safra Sarasin Holding AG Sells 7,283 Shares of The Clorox Company $CLX

J. Safra Sarasin Holding AG decreased its stake in The Clorox Company (NYSE:CLX) by 50.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,017 shares of the company’s stock after selling 7,283 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Clorox were worth $865,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Stonegate Investment Group LLC raised its stake in Clorox by 5.2% during the 3rd quarter. Stonegate Investment Group LLC now owns 3,081 shares of the company’s stock worth $380,000 after acquiring an additional 152 shares during the period. Triton Financial Group Inc increased its stake in shares of Clorox by 2.4% in the third quarter. Triton Financial Group Inc now owns 7,413 shares of the company’s stock worth $914,000 after purchasing an additional 173 shares in the last quarter. CFS Investment Advisory Services LLC raised its position in shares of Clorox by 5.7% during the 3rd quarter. CFS Investment Advisory Services LLC now owns 2,733 shares of the company’s stock valued at $317,000 after purchasing an additional 148 shares during the period. Vanguard Personalized Indexing Management LLC raised its position in shares of Clorox by 64.2% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 25,732 shares of the company’s stock valued at $3,173,000 after purchasing an additional 10,065 shares during the period. Finally, Cullen Frost Bankers Inc. boosted its holdings in Clorox by 1.3% in the 3rd quarter. Cullen Frost Bankers Inc. now owns 54,526 shares of the company’s stock worth $6,723,000 after buying an additional 693 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on CLX. Wells Fargo & Company raised their price target on Clorox from $108.00 to $115.00 and gave the company an “equal weight” rating in a report on Friday, January 23rd. Wall Street Zen cut Clorox from a “hold” rating to a “sell” rating in a research report on Saturday, January 24th. Morgan Stanley lowered their price target on Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Clorox from $110.00 to $114.00 and gave the company a “hold” rating in a report on Friday, January 23rd. Finally, TD Cowen reiterated a “hold” rating on shares of Clorox in a research report on Thursday, January 8th. One investment analyst has rated the stock with a Buy rating, thirteen have issued a Hold rating and four have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $122.19.

Clorox Stock Down 3.9%

Shares of CLX opened at $108.83 on Thursday. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The stock has a market capitalization of $13.28 billion, a price-to-earnings ratio of 17.08, a price-to-earnings-growth ratio of 0.56 and a beta of 0.58. The Clorox Company has a 1 year low of $96.66 and a 1 year high of $161.45. The business’s 50 day simple moving average is $104.50 and its 200-day simple moving average is $114.46.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Clorox had a net margin of 11.68% and a return on equity of 358.39%. Clorox’s quarterly revenue was down 18.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be issued a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. Clorox’s dividend payout ratio (DPR) is presently 77.86%.

Insider Buying and Selling

In related news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction on Friday, November 21st. The shares were bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.63% of the company’s stock.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.